ROYAL BANK OF CANADA - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 3 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 2.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$179,000
-26.6%
56,447
+15.3%
0.00%
Q2 2023$244,000
+10.4%
48,974
+9.1%
0.00%
Q1 2023$221,000
-16.3%
44,870
+7.1%
0.00%
Q4 2022$264,000
-43.6%
41,908
-3.2%
0.00%
Q3 2022$468,000
-5.5%
43,304
-0.4%
0.00%
Q2 2022$495,000
+15.9%
43,490
-7.3%
0.00%
Q1 2022$427,000
-56.0%
46,919
-27.8%
0.00%
Q4 2021$970,000
-59.9%
64,985
-30.9%
0.00%
-100.0%
Q3 2021$2,417,000
-0.4%
94,037
+1.0%
0.00%0.0%
Q2 2021$2,426,000
-24.3%
93,066
+2.5%
0.00%0.0%
Q1 2021$3,205,000
+194.8%
90,791
+111.0%
0.00%
Q4 2020$1,087,000
-30.1%
43,035
+4.4%
0.00%
-100.0%
Q3 2020$1,554,000
-33.0%
41,221
-23.9%
0.00%0.0%
Q2 2020$2,321,000
+212.0%
54,192
+41.5%
0.00%
Q1 2020$744,000
-22.5%
38,297
+3.7%
0.00%
Q4 2019$960,000
+16.5%
36,948
+22.3%
0.00%
Q3 2019$824,000
+33.5%
30,217
+31.5%
0.00%
Q2 2019$617,000
+22.7%
22,976
+32.2%
0.00%
Q1 2019$503,000
+5.0%
17,385
-2.3%
0.00%
Q4 2018$479,00017,7920.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
VV Manager LLC 1,798,163$76,997,00067.53%
Wildcat Capital Management, LLC 1,515,524$64,895,00022.42%
TPG Group Holdings (SBS) Advisors, Inc. 19,716,306$844,252,00014.91%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 1,279,281$54,779,0007.69%
Coastal Bridge Advisors, LLC 463,117$19,831,0006.33%
DSAM Partners (London) Ltd 235,098$10,067,0002.63%
Casdin Capital, LLC 625,000$26,763,0001.58%
Alpine Global Management, LLC 150,000$6,423,0001.13%
Perceptive Advisors 1,543,790$66,105,0001.07%
Avoro Capital Advisors LLC 1,128,594$48,326,0000.96%
View complete list of ALLOGENE THERAPEUTICS INC shareholders